
Commercial paper (CP) is a short-term unsecured debt instrument aimed at institutional investors. CPs are normally issued at a discount and redeemed at nominal value. The term of CPs generally lies between 1 and 364 days. CPs are therefore a way of obtaining short-term funding on the capital markets. Bayer’s global commercial paper program allows the company to issue commercial papers on both the U.S. market (USCP) and the European market (ECP).
Information Memorandum: |
|
Issuers: | Bayer AG, Deutschland |
Guarantor: | Bayer AG |
Total amount: | USD 8,000,000,000 or equivalent |
Arranger: | Deutsche Bank |
ECP Dealers: | Commerzbank, Deutsche Bank, Goldman Sachs, Morgan Stanley |
USCP Dealers: | Credit Suisse First Boston, Deutsche Bank, Goldman Sachs, Morgan Stanley |
Agent: | JP Morgan Chase Bank |